Skip to main content
SpringerLink
Log in

Mechanical Circulatory Support as Bridge to Candidacy

  • Chapter
  • First Online:
Mechanical Circulatory Support in End-Stage Heart Failure

  • 1846 Accesses

Abstract

Implant of long-term mechanical circulatory support (MCS), ventricular assist device (VAD), or total artificial heart (TAH) in patients who are not yet on the heart transplant (HTX) waiting list, in whom actual or future eligibility for HTX has been neither ascertained nor excluded, is not uncommon in clinical practice. This strategy can be defined as “bridge to candidacy” (BTC); including in this group also are patients with the highest degree of uncertainty, in whom MCS strategy is sometimes classified as “bridge to decision.”

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. The Data and Clinical Coordinating Center University of Alabama at Birmingham Intermacs (Interagency Registry for Mechanically Assisted Circulatory Support). Quarterly statistical report (2015) Q3 – Implant and event dates: 23 June 2006 to 30 September 2015. Available at ► https://www.uab.edu/medicine/intermacs/images/Federal_Quarterly_Report/Statistical_Summaries/Federal_Partners_Report_2015_Q3.pdf. Accessed on 14 Jan 2016

  2. Feltrin G, Frigerio M, Martinelli L et al (2015) Preliminary results from ITAMACS, the Italian Multi Center Registry for Mechanically Assisted Circulatory Support. J Heart Lung Transplant 34(Suppl):S11–S12

    Article  Google Scholar 

  3. de By TM, Mohacsi P, Gummert J et al (2015) The European Registry for Patients with Mechanical Circulatory Support (EUROMACS): first annual report. Eur J Cardiothorac Surg 47:770–776; (discussion 776–7)

    Google Scholar 

  4. Teuteberg JJ, Stewart JC, Jessup M et al (2013) Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). JACC Heart Fail 1:369–378

    Article  PubMed  Google Scholar 

  5. Fang JC, Stehlik J (2013) Moving beyond “bridges”. JACC Heart Fail 1:379–381

    Article  PubMed  Google Scholar 

  6. Mehra, MR, Canter CE, Hannan MM et al, On Behalf of the International Society for Heart Lung Transplantation (ISHLT) Infectious Diseases, Pediatric and Heart Failure and Transplantation Councils (2016) The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant 35:1–23

    Google Scholar 

  7. Chaudhry UI, Kanji A, Sai-Sudhakar CB, Higgins RS, Needleman BJ (2015) Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist adevice: medium-term results. Surg Obes Relat Dis Off J Am Soc Bariatric Surg 11:88–93

    Article  Google Scholar 

  8. Singh TP, Milliren CE, Almond CS, Graham D (2014) Survival benefit of transplantation in patients listed for heart transplantation in the United States. J Am Coll Cardiol 63:1169–1178

    Article  PubMed  Google Scholar 

  9. Wever-Pinzon O, Drakos SG, Kfoury AG et al (2013) Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation 127:452–462

    Article  PubMed  Google Scholar 

  10. Wozniak CJ, Stehlik J, Baird BC (2014) Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the United Network of Organ Sharing database. Ann Thorac Surg 97(4):1364–71; discussion 1371–2

    Google Scholar 

  11. Mikus E, Stepanenko A, Krabatsch T et al (2011) Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. Eur J Cardiothorac Surg 40:971–977

    PubMed  Google Scholar 

  12. Kutty RS, Parameshwar J, Lewis C et al (2013) Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension. Eur J Cardiothorac Surg 43:1237–1242

    Article  PubMed  Google Scholar 

  13. Gupta S, Woldendorp K, Ke M et al (2014) Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy. Heart Lung Circ 23:963–969

    Article  PubMed  Google Scholar 

  14. Atluri P, Fairman AS, MacArthur JW et al (2013) Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence. J Card Surg 28:770–775

    Article  PubMed  PubMed Central  Google Scholar 

  15. Alba AC, Rao V, Ross HJ et al (2010) Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients. J Heart Lung Transplant 29:1253–1258

    Article  PubMed  Google Scholar 

  16. Nair PK, Kormos RL, Teuteberg JJ (2010) Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant 29:201–208

    Article  PubMed  PubMed Central  Google Scholar 

  17. Liden H, Haraldsson A, Ricksten SE, Kjellman U, Wiklund L (2009) Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance? Eur J Cardiothorac Surg 35:1029–1034 ; discussion 1034-5

    Article  PubMed  Google Scholar 

  18. Etz CD, Welp HA, Tjan TD et al (2007) Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg 83:1697–1705

    Article  PubMed  Google Scholar 

  19. LaRue SJ, Garcia-Cortes R, Nassif ME et al (2015) Treatment of secondary pulmonary hypertension with bosentan after left ventricular assist device implantation. Cardiovasc Ther 33:50–55

    Article  CAS  PubMed  Google Scholar 

  20. Tedford RJ, Hemnes AR, Russell SD et al (2008) PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail 1:213–219

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Galiè N, Humbert M, Vachiery JL (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67–119

    Article  PubMed  Google Scholar 

  22. Burkhoff D, Maurer MS, Joseph SM et al (2015) Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations. JACC Heart Fail 3:275–282

    Article  PubMed  Google Scholar 

  23. Lund LH, Edwards LB, Kucheryavaya AY et al (2015) Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report—2015; focus theme: early graft failure. J Heart Lung Transplant 34:1244–1254

    Article  PubMed  Google Scholar 

  24. Grulich AE, Vajdic CM (2015) The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation. Semin Oncol 42:247–257

    Article  PubMed  Google Scholar 

  25. Mistiaen WP (2015) Heart transplantation in patients with previous malignancy. An overview. Acta Cardiol 70:123–130

    Article  PubMed  Google Scholar 

  26. Rivinius R, Helmschrott M, Ruhparwar A et al (2015) Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy. Drug Des Devel Ther 9:93–102

    PubMed  Google Scholar 

  27. Doesch AO, Müller S, Konstandin M et al (2010) Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal. Transplant Proc 42:3694–3699

    Article  CAS  PubMed  Google Scholar 

  28. Shah S, Nohria A (2015) Advanced heart failure due to cancer therapy. Curr Cardiol Rep 17:16

    Article  PubMed  Google Scholar 

  29. Deo SV, Al-Kindi SG, Oliveira GH (2015) Management of advanced heart failure due to cancer therapy: the present role of mechanical circulatory support and cardiac transplantation. Curr Treat Options Cardiovasc Med 17:388

    Article  PubMed  Google Scholar 

  30. Sayin OA, Ozpeker C, Schoenbrodt M (2015) Ventricular assist devices in patients with chemotherapy-induced cardiomyopathy: new modalities. Acta Cardiol 70:430–434

    Article  PubMed  Google Scholar 

  31. Rosa GM, Gigli L, Tagliasacchi MI et al (2016) Update on cardiotoxicity of anti-cancer treatments. Eur J Clin Investig 46:264–284

    Article  Google Scholar 

  32. Oliveira GH, Dupont M, Naftel D (2014) Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 63:240–248

    Article  PubMed  Google Scholar 

  33. Smail H, Pfister C, Baste JM et al (2015) A difficult decision: what should we do when malignant tumours are diagnosed in patients supported by left ventricular assist devices? Eur J Cardiothorac Surg 48:e30–e36

    Article  PubMed  Google Scholar 

  34. Loyaga-Rendon RY, Inampudi C, Tallaj JA, Acharya D, Pamboukian SV (2014) Cancer in end-stage heart failure patients supported by left ventricular assist devices. ASAIO J 60:609–612

    Article  PubMed  Google Scholar 

  35. Murakawa T, Murayama T, Nakajima J, Ono M (2011) Lung lobectomy in a patient with an implantable left ventricular assist device. Interact Cardiovasc Thorac Surg 13:676–678

    Article  PubMed  Google Scholar 

  36. Chelikani NM, Masterson K, Down LA et al (2012) Effects of gamma radiation on a ventricular assist device and its percutaneous lead components. ASAIO J 58:19–24

    Article  PubMed  Google Scholar 

  37. Gossman MS, Graham JD, Das IJ (2012) Evaluation of a ventricular assist device system: stability in a proton beam therapy. ASAIO J 58:597–600

    Article  PubMed  Google Scholar 

  38. Netuka I, Stepankova P, Urban M et al (2013) Is severe cardiac dysfunction a contraindication for complex combined oncotherapy of Hodgkin’s lymphoma? Not any more. ASAIO J 59:320–321

    Article  PubMed  Google Scholar 

  39. McCarthy PM, Lamm RD, Sade RM (2005) Medical ethics collides with public policy: LVAD for a patient with leukemia. Ann Thorac Surg 80:793–780

    Article  PubMed  Google Scholar 

  40. Teuteberg JJ, Chou JC (2014) Mechanical Circulatory Devices in acute heart failure. Crit Care Clin 30:585–606

    Article  PubMed  Google Scholar 

  41. Cole RM, Kobashigawa JA (2016) Desensitization strategies pre- and post-cardiac transplantation. Curr Treat Options 18:8

    Article  Google Scholar 

  42. Chih S, Ross HJ, McDonald MA, Issac DL (2012) Highly sensitized patients in cardiac transplantation: early outcomes from the Canadian Prioritized Organ Sharing Program. J Heart Lung Transplant 31:780–782

    Article  PubMed  Google Scholar 

  43. Kfoury AG, Kobashigawa JA (2012) Prioritizing sensitized heart transplant candidates: a sensitive affair. J Heart Lung Transplant 31:677–678

    Article  PubMed  Google Scholar 

  44. Urban M, Gazdic T, Slimackova E et al (2012) Alloimmunosensitization in left ventricular assist device recipients and impact on post-transplantation outcome. ASAIO J 58:554–561

    Article  CAS  PubMed  Google Scholar 

  45. Arnaoutakis GJ, George TJ, Kilic A et al (2011) Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. J Thorac Cardiovasc Surg 142:1236–1245

    Article  PubMed  PubMed Central  Google Scholar 

  46. Chang D, Kobashigawa JA (2012) The use of calculated panel-reactive antibody and virtual crossmatch in heart transplantation. Curr Opin Organ Transplant 17:423–426

    CAS  PubMed  Google Scholar 

  47. Bhimaraj A, Taylor DO (2011) How to deal with presensitized candidates for heart transplantation? Curr Opin Organ Transplant 16:529–535

    Article  CAS  PubMed  Google Scholar 

  48. Kobashigawa JA, Johnson M, Rogers J et al (2015) Report from a Forum on US Heart Allocation Policy. Am J Transplant 15:55–63

    Article  CAS  PubMed  Google Scholar 

  49. Stehlik J, Stevenson LW, Edwards LB et al (2014) Organ allocation around the world: insights from the ISHLT International Registry for Heart and Lung Transplantation. J Heart Lung Transplant 33:975–984

    Article  PubMed  Google Scholar 

  50. Thiele H, Zeymer U, Neumann FJ et al (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 2013(382):1638–1645

    Article  Google Scholar 

  51. Khera R, Cram P, Vaughan-Sarrazin M, Horwitz PA, Girotra S (2016) Use of mechanical circulatory support in percutaneous coronary intervention in the United States. Am J Cardiol 117:10–16

    Article  PubMed  Google Scholar 

  52. Link MS, Berkow LC, Kudenchuk PJ et al (2015) Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 132(Suppl 2):S444–S464

    Article  PubMed  Google Scholar 

  53. Taghavi S, Jayarajan SN, Komaroff E, Mangi AA (2014) Continuous flow left ventricular assist device technology has influenced wait times and affected donor allocation in cardiac transplantation. J Thorac Cardiovasc Surg 147:1966–1971

    Article  PubMed  Google Scholar 

  54. Meyer DM, Rogers JG, Edwards LB (2015) The future direction of the adult heart allocation system in the United States. Am J Transplant 15:44–54

    Article  CAS  PubMed  Google Scholar 

  55. Kirklin JK, Naftel DC, Pagani FD et al (2015) Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant 34:1495–1504

    Article  PubMed  Google Scholar 

  56. Kirklin JK, Naftel DC, Kormos RL et al (2010) Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 29:1–10

    Article  PubMed  PubMed Central  Google Scholar 

  57. Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH (2013) Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database. Ann Thorac Surg 95:870–875

    Article  PubMed  Google Scholar 

  58. Healy AH, Stehlik J, Edwards LB, McKellar SH, Drakos SG, Selzman CH (2016) Risk of 30-day post-transplant mortality in patients bridged to transplantation with continuous-flow left ventricular assist devices-an analysis of the international society for heart and lung transplantation transplant registry. J Heart Lung Transplant 35:34–39

    Article  PubMed  Google Scholar 

  59. Estep JD, Starling RC, Horstmanshof DA et al (2015) Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP Study, for the ROADMAP Study Investigators. J Am Coll Cardiol 66:1747–1761

    Article  PubMed  Google Scholar 

  60. Mancini D, Colombo P (2015) Left ventricular assist devices: a rapidly evolving alternative to transplant. J Am Coll Cardiol 65:2542–2555

    Article  PubMed  Google Scholar 

  61. Smits J, DeUries E, De Pauw M et al (2013) Is it time for a cardiac allocation score? First results from the Eurotransplant pilot on survival benefit based heart allocation. J Heart Lung Transplant 32:873–880

    Article  PubMed  Google Scholar 

  62. Mancini DM, Schulze PC (2014) Heart transplant allocation: in desperate need of revision. J Am Coll Cardiol 63:1179–1181

    Article  PubMed  Google Scholar 

  63. Barr ML, Taylor DO (2015) Changes in donor heart allocation in the United States wfundamental changes in the system: rearranging deck chairs and elephants in the room. Am Journal Transplant 15:7–9

    Article  CAS  Google Scholar 

  64. Stevenson LW (2013) The urgent priority for transplantation is to trim the waiting list. J Heart Lung Transplant 32:861–867

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. “A. De Gasperis” CardioCenter, Niguarda Hospital, Piazza Ospedale Maggiore 3, 20162, Milan, Italy

    Maria Frigerio

  2. “A. De Gasperis” CardioCenter, Niguarda Great Metropolitan Hospital, Milan, Italy

    Maria Frigerio

  3. “A. De Gasperis” CardioCenter, Niguarda Great Metropolitan Hospital, Milan, Italy

    Manlio Cipriani

  4. University of Cincinnati Medical Center, Cincinnati, OH, USA

    David Feldman

Authors
  1. Maria Frigerio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manlio Cipriani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Feldman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Frigerio .

Editor information

Editors and Affiliations

  1. San Camillo-Forlanini Hospital, Rome, Italy

    Andrea Montalto

  2. Cardiac Surgery, S.Orsola-Malpighi Hospital, Bologna, Italy

    Antonio Loforte

  3. San Camillo-Forlanini Hospital, Rome, Italy

    Francesco Musumeci

  4. Deutsches Herzzentrum Berlin, Berlin, Germany

    Thomas Krabatsch

  5. Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, Kentucky, USA

    Mark S. Slaughter

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Frigerio, M., Cipriani, M., Feldman, D. (2017). Mechanical Circulatory Support as Bridge to Candidacy. In: Montalto, A., Loforte, A., Musumeci, F., Krabatsch, T., Slaughter, M. (eds) Mechanical Circulatory Support in End-Stage Heart Failure. Springer, Cham. https://doi.org/10.1007/978-3-319-43383-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43383-7_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43381-3

  • Online ISBN: 978-3-319-43383-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation